Related Experiment Video
Updated: Jul 30, 2025
09:06
Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice
Published on: February 20, 2019
8.4K
Branch atheromatous disease and treatment
Honglian Duan1, Ho Jun Yun2, Xiaokun Geng1,2,3
1Department of Neurology, Beijing Luhe Hospital, Capital Medical University, Beijing, China.
Brain Circulation
|May 14, 2023
Summary
Branch atheromatous disease (BAD), a stroke subtype from artery blockage, often causes early decline and repeated attacks. This review examines BAD mechanisms and treatments like thrombolysis and anticoagulants to prevent further events.
Area of Science:
- Neurology
- Vascular Medicine
- Cerebrovascular Diseases
Background:
- Branch atheromatous disease (BAD) is an ischemic stroke subtype.
- It results from perforating artery occlusion due to atherosclerosis.
- BAD presents with early neurological deterioration and recurrent transient ischemic attacks.
Purpose of the Study:
- To explore the mechanism of BAD.
- To identify effective treatments for preventing early progression and transient ischemic events in BAD.
- To review current treatment options including intravenous thrombolysis, tirofiban, and argatroban.
Main Methods:
- Literature review of BAD mechanisms and treatments.
- Analysis of current therapeutic strategies for BAD.
- Evaluation of the prognosis associated with different treatments.
Main Results:
- BAD is characterized by specific clinical manifestations.
- Optimal treatment for BAD remains undetermined.
- Intravenous thrombolysis, tirofiban, and argatroban are discussed as potential treatments.
Conclusions:
- Understanding BAD mechanisms is crucial for effective management.
- Further research is needed to establish optimal treatment protocols for BAD.
- Timely and appropriate interventions may improve outcomes for BAD patients.
Related Concept Videos
01:26Atherosclerosis III: Management
16
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
16
01:27Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
18
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
18
01:23Atherosclerosis IV: Nursing Management
29
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
29
01:27Peripheral Artery Disease III: Interprofessional Care
14
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
14
01:30Atherosclerosis I: Introduction
15
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
15
01:27Coronary Artery Disease V: Interprofessional Care
12
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
12